EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques

Siva Thirugnanam, Edith M Walker, Faith Schiro, Pyone P Aye, Jay Rappaport, Namita Rout

Viruses · 2023

DOI: 10.3390/v15091944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Siva Thirugnanam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tulane National Primate Research Center, Covington, LA 70433, USA. Hauptthemen laut MEDLINE: HIV Infections, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have indicated that the loss of CD161-expressing CD4+ Th17 cells is linked to the progression of chronic HIV. These cells are significantly depleted in peripheral blood and gut mucosa of HIV-infected individuals, contributing to inflammation and disruption of the gut barrier. However, the impact of HIV infection on CD161-expressing CD8+ T cells remain unclear. Here, we examined the functions of peripheral blood and mucosal CD161+CD8+ T cells in the macaque model of HIV infection. In contrast to the significant loss of CD161+CD4+ T cells, CD161+CD8+ T cell frequencies were maintained in blood and gut during chronic SIV infection. Furthermore, gut CD161+CD8+ T cells displayed greater IL-17 production and maintained Th1-type and cytolytic functions, contrary to impaired IL-17 and granzyme-B production in CD161+CD4+ T cells of SIV-infected macaques. These results suggest that augmented Th17-type effector functions of CD161+CD8+ T cells during SIV infection is a likely mechanism to compensate for the sustained loss of gut mucosal Th17 cells. Targeting the cytokine and cytolytic effector functions of CD161+CD8+ T cells in the preclinical setting of chronic SIV infection with antiretroviral therapy has implications in the restoration of gut barrier disruption in persons with HIV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsHumansCD8-Positive T-LymphocytesMacaca mulattaInterleukin-17Intestinal Mucosa

Stichwörter der Autor:innen

CD161IL-17SIVT cellsTNF-αmucosal immunity

Substanzen

Interleukin-17

Autor:innen und Institutionen

  • Tulane National Primate Research Center, Covington, LA 70433, USA.
  • Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NIMH NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Thirugnanam, S., Walker, E. M., Schiro, F., Aye, P. P., Rappaport, J., & Rout, N. (2023). Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques. Viruses. https://doi.org/10.3390/v15091944

Vancouver

Thirugnanam S, Walker EM, Schiro F, Aye PP, Rappaport J, Rout N. Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques. Viruses. 2023. doi:10.3390/v15091944

BibTeX
@article{Thirugnanam2023,
  author = {Thirugnanam, Siva and Walker, Edith M and Schiro, Faith and Aye, Pyone P and Rappaport, Jay and Rout, Namita},
  title = {Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15091944}
}
Kostenlos starten →